(Q36845805)

16 August 2017

Lessons learned from a highly-active CD22-specific chimeric antigen receptor (English)

1 reference

16 August 2017

1 reference

Adrienne H Long

1

1 reference

16 August 2017

Waleed M Haso

series ordinal

2

1 reference

16 August 2017

Rimas J Orentas

series ordinal

3

1 reference

16 August 2017

1 April 2013

1 reference

16 August 2017

1 reference

16 August 2017

2

1 reference

16 August 2017

4

1 reference

16 August 2017

e23621

1 reference

How do CARs work?: Early insights from recent clinical studies targeting CD19.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

Identification and characterization of fully human anti-CD22 monoclonal antibodies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654586

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

29 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23734316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23734316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.23621

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23734316

1 reference